{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:41:34Z","timestamp":1793122894296,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2019\u201301486"],"award-info":[{"award-number":["2019\u201301486"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018\u201302535"],"award-info":[{"award-number":["2018\u201302535"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Heart and Lung Foundation","award":["20180571"],"award-info":[{"award-number":["20180571"]}]},{"name":"Swedish Heart and Lung Foundation","award":["20170257"],"award-info":[{"award-number":["20170257"]}]},{"name":"King Gustaf V and Queen Victoria Freemason Foundation,"},{"name":"Region Stockholm County Council","award":["20170365"],"award-info":[{"award-number":["20170365"]}]},{"name":"Region Stockholm County Council","award":["20170038"],"award-info":[{"award-number":["20170038"]}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","award":["SLS-713911"],"award-info":[{"award-number":["SLS-713911"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ingegerd Johansson Donation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The antiphospholipid syndrome is defined by antiphospholipid antibodies (aPL) together with arterial and\/or venous thromboembolism and\/or obstetric morbidities. aPL are overrepresented in SLE and acute myocardial infarction, but it is unknown whether aPL are associated with calcific aortic valve stenosis (CAVS) in the general population. The prevalence of aPL and other SLE-associated autoantibodies and their impact on aortic valve transcriptomics were therefore determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 233 tricuspid CAVS cases (median age 74, 69% male) and an age- and sex-matched control population were included. aPL were measured as anti-cardiolipin and anti-\u03b22Glycoprotein-I of IgG\/M\/A isotypes. Resilient, thickened and calcified aortic valve (AV) tissue derived from five aPL positive and five matched aPL negative CAVS patients undergoing surgical aortic valve replacement were analysed by microarrays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of positivity for any aPL (IgG\/M\/A) in patients with CAVS was 6.4% (95% CI 3.6% \u2013 10.4%: n\u2009=\u2009233). aPL IgG was significantly more prevalent in CAVS cases vs controls (4.6% vs 0.6%, P\u2009=\u20090.04). AV tissue from aPL IgG\/IgM-positive patients was negatively enriched in pathways related to interferon signalling. One hundred differentially expressed genes could predict local AV CAVS progression with supervised machine learning algorithms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>aPL IgG was more common in CAVS patients compared with matched controls and aPL positivity was associated with altered AV transcriptomics related to local disease progression and interferon pathways. Further studies should aim to establish aPL as a possible risk marker and\/or causal factor for CAVS and could offer new precision therapeutic targets.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keac466","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T21:42:54Z","timestamp":1660340574000},"page":"1187-1196","source":"Crossref","is-referenced-by-count":8,"title":["Antiphospholipid antibodies in patients with calcific aortic valve stenosis"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-2198","authenticated-orcid":false,"given":"Oscar","family":"Plunde","sequence":"first","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet"},{"name":"Theme Heart and Vessels"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-3244","authenticated-orcid":false,"given":"Elisabet","family":"Svenungsson","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet"},{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferrannini","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet"},{"name":"Theme Heart and Vessels"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Franco-Cereceda","sequence":"additional","affiliation":[{"name":"Theme Heart and Vessels"},{"name":"Cardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"B\u00e4ck","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska Institutet"},{"name":"Theme Heart and Vessels"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"16006","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/CIRCRESAHA.110.234146","article-title":"Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification","volume":"108","author":"New","year":"2011","journal-title":"Circ Res"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterization of the early lesion of \u2018degenerative\u2019 valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00125-019-05019-0","article-title":"Association of genetic variants related to plasma fatty acids with type 2 diabetes mellitus and glycaemic traits: a Mendelian randomisation study","volume":"63","author":"Yuan","year":"2020","journal-title":"Diabetologia"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcvm.2019.00018","article-title":"Autotaxin and lipoprotein metabolism in calcific aortic valve disease","volume":"6","author":"Mathieu","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023030119163482700_","first-page":"2016","volume-title":"Cardiovasc Res","author":"B\u00e4ck","year":"2021"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","article-title":"Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies","volume":"124","author":"Zuily","year":"2011","journal-title":"Circulation"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7326\/M18-2130","article-title":"Antiphospholipid antibodies in patients with myocardial infarction","volume":"170","author":"Grosso","year":"2019","journal-title":"Ann Intern Med"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/joim.13409","article-title":"Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries","volume":"291","author":"Svenungsson","year":"2022","journal-title":"J Intern Med"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2019.10.042","article-title":"Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population","volume":"300","author":"Selmi","year":"2020","journal-title":"Int J Cardiol"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/heartjnl-2020-318733","article-title":"Relative survival after aortic valve surgery in patients with bicuspid aortic valves","volume":"107","author":"Glaser","year":"2021","journal-title":"Heart"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/cclm-2013-0741","article-title":"The revised Lund-Malm\u00f6 GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population","volume":"52","author":"Nyman","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"e002710","DOI":"10.1161\/CIRCGEN.119.002710","article-title":"FADS1 (Fatty Acid Desaturase 1) genotype associates with aortic valve FADS mRNA expression, fatty acid content and calcification","volume":"13","author":"Plunde","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCGENETICS.110.948935","article-title":"Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease","volume":"3","author":"Folkersen","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"New Engl J Med"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2009.115535","article-title":"A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus","volume":"69","author":"Svenungsson","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"e0156407","DOI":"10.1371\/journal.pone.0156407","article-title":"Measuring IgA Anti-\u03b22-glycoprotein I and IgG\/IgA anti-domain I antibodies adds value to current serological assays for the antiphospholipid syndrome","volume":"11","author":"Pericleous","year":"2016","journal-title":"PLoS one"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.15585","article-title":"Semiquantitative interpretation of anticardiolipin and anti-\u03b22-glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J Thromb Haemost"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/jth.13379","article-title":"IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis","volume":"14","author":"Kelchtermans","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/ATVBAHA.118.311504","article-title":"Calcification induced by type I interferon in human aortic valve interstitial cells is larger in males and blunted by a janus kinase inhibitor","volume":"38","author":"Parra-Izquierdo","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2019.00487","article-title":"Type I interferon signature in primary antiphospholipid syndrome: clinical and laboratory associations","volume":"10","author":"Palli","year":"2019","journal-title":"Front Immunol"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.celrep.2018.09.002","article-title":"IFIT1 exerts opposing regulatory effects on the inflammatory and interferon gene programs in LPS-activated human macrophages","volume":"25","author":"John","year":"2018","journal-title":"Cell Rep"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.110.177915","article-title":"Tumor necrosis factor-\u03b1 accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway","volume":"337","author":"Yu","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCRESAHA.108.192765","article-title":"Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades","volume":"104","author":"AbouAlaiwi","year":"2009","journal-title":"Circ Res"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.atherosclerosis.2007.05.030","article-title":"Endothelial primary cilia in areas of disturbed flow are at the base of atherosclerosis","volume":"196","author":"Van der Heiden","year":"2008","journal-title":"Atherosclerosis"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0092-8674(01)00628-6","article-title":"Cytoplasmic dynein as a facilitator of nuclear envelope breakdown","volume":"108","author":"Salina","year":"2002","journal-title":"Cell"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCULATIONAHA.121.054182","article-title":"Palmdelphin regulates nuclear resilience to mechanical stress in the endothelium","volume":"144","author":"S\u00e1inz-Jaspeado","year":"2021","journal-title":"Circulation"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacbts.2021.02.005","article-title":"Artificial intelligence models reveal sex-specific gene expression in aortic valve calcification","volume":"6","author":"Sarajlic","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1055\/s-0039-1685453","article-title":"Platelet activation by antiphospholipid antibodies depends on epitope specificity and is prevented by mTOR inhibitors","volume":"119","author":"Hollerbach","year":"2019","journal-title":"Thromb Haemost"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/eurheartj\/ehy696","article-title":"Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis","volume":"40","author":"Bouchareb","year":"2019","journal-title":"Eur Heart J"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacbts.2021.07.008","article-title":"Platelets: implications in aortic valve stenosis and bioprosthetic valve dysfunction from pathophysiology to clinical care","volume":"6","author":"Sellers","year":"2021","journal-title":". JACC Basic Transl Sci"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2249.1997.d01-948.x","article-title":"Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages","volume":"107","author":"Hasunuma","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via \u03b22GPI and apoER2","volume":"121","author":"Ramesh","year":"2011","journal-title":"J Clin Invest"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023030119163482700_","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis\u2013from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac466\/45600133\/keac466.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1187\/49356003\/keac466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/3\/1187\/49356003\/keac466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T19:05:22Z","timestamp":1700939122000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/3\/1187\/6664008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,8,12]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac466","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,8,12]]}}}